Gsk

GSK grows in Asia vacc market

GSK grows in Asia vacc market

By Gareth Macdonald

UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.